Original Article

Changing Age Distribution of Melanoma Patients: A 22-Year, Single-Site Perspective

Authors: Joan Paul MD, MPH, Jennifer A. Sbicca, MD, Stefanie A. Hirano, MD, Sirisha Mushti, MSc, Robert J. Pariser, MD

Abstract

Objectives: To investigate possible changes in the demographics of patients with melanoma during a period of 22 years in one dermatopathology practice.

Methods: We performed a retrospective review of 1835 cases of in situ and invasive melanomas histologically diagnosed between 1989 and 2010 in a private dermatopathology laboratory in Norfolk, Virginia. The age and sex of patients with in situ and invasive melanomas were recorded and compared with similar data for patients from whom any histopathologic specimen was received during the same interval. These data were then compared with those in the national Surveillance, Epidemiology, and End Results (SEER) registry between 1989 and 2009.

Results: The number of melanomas diagnosed in the laboratory increased during the 22 study years, but the proportion of submitted specimens diagnosed as melanoma remained somewhat stable. Patient ages ranged from the teens to the ninth decade of life. The proportion of melanomas in the in situ stage gradually increased. Mean patient age rose from 52.4 years in 1989 to 60.7 years in 2010. Men and women aged 60 years and older made up an increasing proportion of melanoma cases. There also was a relative increase in the proportion of women in the 40- to 50-year-old age group and a slight increase among those aged 20 to 30 years, particularly for invasive lesions. In general, the trends were similar for in situ and invasive melanomas. Our data were consistent with the SEER data in showing a trend for decreasing proportion of melanomas in younger individuals, with a corresponding increase in the middle-age and older adult populations. Some differences between the two datasets emerged for men aged 70 to 80, women aged 60 to 70, and all patients aged 70 to 80.

Conclusions: An increasing proportion of melanomas were diagnosed in older individuals. There also was a relative increase in women aged 40 to 50 years and a lesser increase in those aged 20 to 30 years. Our findings were consistent with the national trends observed in the SEER dataset.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol. 2009; 27: 3–9.
 
2. Kohler BA, Ward E, McCarthy BJ, et al. Annual report to the nation on the status of cancer, 1975–2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst. 2011; 103: 714–736.
 
3. Howlader N, Noone AM, Krapcho M, et al. , eds. SEER cancer statistics review, 1975−2008. http://seer.cancer.gov/csr/1975_2008http://seer.cancer.gov/csr/1975_2008. Published 2011. Accessed September 17, 2012
 
4. Bradford PT, Anderson WF, Purdue MP, et al. Rising melanoma incidence rates of the trunk among younger women in the United States. Cancer Epidemiol Biomarkers Prev. 2010; 19: 2401–2406.
 
5. Purdue MP, Freeman LE, Anderson WF, et al. Recent trends in incidence of cutaneous melanoma among US Caucasian young adults. J Invest Dermatol. 2008; 128: 2905–2908.
 
6. Héry C, Tryggvadóttir L, Sigurdsson T, et al. A melanoma epidemic in Iceland: possible influence of sunbed use. Am J Epidemiol. 2010; 172: 762–767.
 
7. Hausauer AK, Swetter SM, Cockburn MG, et al. Increases in melanoma among adolescent girls and young women in California: trends by socioeconomic status and UV radiation exposure. Arch Dermatol. 2011; 147: 783–789.
 
8. Linos E, Swetter SM, Cockburn MG, et al. Increasing burden of melanoma in the United States. J Invest Dermatol. 2009; 129: 1666–1674.
 
9. Geller AC, Miller DR, Annas GD, et al. Melanoma incidence and mortality among US whites, 1969–1999. JAMA. 2002; 288: 1719–1720.
 
10. Wallingford SC, Alston RD, Birch JM, et al. Increases in invasive melanoma in England, 1979–2006, by anatomical site. Br J Dermatol. 2011; 165: 859–864.
 
11. Watson M, Johnson CJ, Chen VW, et al. Melanoma surveillance in the United States: overview of methods. J Am Acad Dermatol. 2011; 65: s6–s16.
 
12. Richards TB, Johnson CJ, Tatalovich Z, et al. Association between cutaneous melanoma incidence rates among white US residents and county-level estimates of solar ultraviolet exposure. J Am Acad Dermatol. 2011; 65: s50–s57.
 
13. Frangos JE, Duncan LM, Piris A, et al. Increased diagnosis of thin superficial spreading melanomas: a 20-year study. J Am Acad Dermatol. 2012; 67: 387–394.
 
14. Glusac EJ. The melanoma “epidemic,” a dermatopathologist’s perspective. J Cutan Pathol. 2011; 38: 264–267.